National Cancer Institute  www.cancer.gov  U.S. National Institutes of Health
 


Cancer Trends Progress Report – 2011/2012 Update

Skip to content
Progress Report  Home

Progress Report
Tools and Resources
  Appendices
  Data Sources (PDF)
  Dictionary
  Fact Sheet (PDF)
  FAQs
 Generate custom report
 Print this page
  Quick Tutorial
  Report Archive



In the Report
Director's Message
Report Highlights
Introduction
Trends-at-a-Glance
Summary Tables
Prevention
Smoking
Clinicians’ Advice to Quit Smoking
Medicaid Coverage of Tobacco Dependence Treatments
Diet
Weight and Physical Activity
Sun Protection
Secondhand Smoke
Chemical Exposures
Tobacco Company Marketing Expenditures
Early Detection
Breast and Cervical Cancers
Colorectal Cancer
Diagnosis
Treatment
Bladder, Breast, Colorectal
Kidney, Lung, Ovarian, Prostate
Life After Cancer
End of Life
Prevention
Early Detection
Diagnosis
Treatment
Life After Cancer
End of Life


Summary Table: Treatment – Kidney, Lung, Ovarian, Prostate

Only one measure per topic is displayed in the summary table. A complete set of measures, where they exist, can be found in the report.

Trend key: green - headed in the right direction
  red - headed in the wrong direction
  black - stable or non-significant change (NSC)
  blue - Healthy People 2020 target


  Kidney cancer treatment
2000–2008
Lung cancer treatment
1996 and 2005
Ovarian cancer treatment
1991, 1996, 2002
Prostate cancer treatment
1998 and 2002
Measure Partial nephrectomy (removal of the part of the kidney) or complete nephrectomy in patients with local-regional disease. Chemotherapy following the diagnosis of stage IIIB or IV non-small cell lung cancer. (Example below is for ages 60–69.) Percentage of women diagnosed with ovarian cancer who received Paclitaxol (Taxol) by stage of diagnosis. (Example below is for stage III or IV.) Hormonal therapy following the diagnosis of prostate cancer. (Example below is for ages 60–69).
Recent summary trend* Rising
2004–2008
Rising
1996–2005
Non-significant change
1996–2002
Non-significant change
1998–2002
Desired direction Rising  Rising  Rising  Rising 
Trend Rising

Rising

Rising, then non-significant change
Non-significant change

Most recent estimate In 2008, the rate of partial nephrectomy was 22 percent. The rate of complete nephrectomy was 62 percent. In 2005, 60 percent of patients diagnosed with stage IIIB or IV non-small cell lung cancer received chemotherapy. In 2002, 61 percent of women with stage III or IV ovarian cancer received Paclitaxol compared to 49 percent with stage I or II disease. In 2002, 29 percent of men aged 6069 with localized/regional prostate cancer were given hormonal therapy.
Healthy People 2020 target There are no Healthy People 2020 targets for cancer treatment, including kidney cancer treatment. There are no Healthy People 2020 targets for cancer treatment, including lung cancer treatment. There are no Healthy People 2020 targets for cancer treatment, including ovarian cancer treatment. There are no Healthy People 2020 targets for cancer treatment, including prostate cancer treatment.
More information Kidney Cancer Treatment Lung Cancer Treatment Ovarian Cancer Treatment Prostate Cancer Treatment

Previous: Treatment - Bladder, Breast, Colorectal

Next: Life After Cancer

 
* Summary trend (generally 5 most recent years) as characterized by the Average Annual Percent Change (AAPC)

National Cancer InstituteDepartment of Health and Human ServicesNational Institutes of HealthUSA.gov

NIH... Turning Discovery Into Health